Showing 41-50 of 5404 results for "".
- Revealed: Why Skin Feels “Tight” After Using a Facial Cleanserhttps://practicaldermatology.com/news/revealed-why-skin-feels-tight-after-using-a-facial-cleanser/2462023/Some cleansers make the skin feel “tight” and some moisturizers make the skin feel “soft,” but exactly why this occurs hasn't been fully understood. To find out, Reinhold H. Dauskardt, the Ruth G. and William K. Bowes Professor in Stanford’s
- Study Links Lichen Planus to Increased Oral and Genital Cancer Riskhttps://practicaldermatology.com/news/study-links-lichen-planus-to-increased-oral-and-genital-cancer-risk/2488704/A nationwide Danish cohort study found that patients with lichen planus (LP) had an increased risk of oral, genital, and cutaneous cancers, with the strongest associations observed at anatomical sites affected by the inflammatory condition. The findings, published in JAMA Dermatology, sh
- Galderma to Acquire ZO Skin Health for $1.5 Billionhttps://practicaldermatology.com/news/galderma-to-acquire-zo-skin-health-for-15-billion-expanding-physician-dispensed-skincare-portfolio/2488703/Galderma announced an agreement to acquire ZO Skin Health for $1.5 billion, a move it says will expand its dermatological skincare business and strengthen its presence in the physician-dispensed skincare market. According to a company press release, the all-cash transaction will transfer f
- Facial Volume Loss, Hair Changes Among GLP-1 Dermatologic Concerns: Analysishttps://practicaldermatology.com/news/facial-volume-loss-hair-changes-among-glp-1-dermatologic-concerns-analysis/2488695/A new narrative review published in Clinics in Dermatology took a closer look at the cutaneous effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs), including facial volume loss, hair changes, skin laxity, and potential benefits in inflammatory skin diseases. Researcher
- Hyperpigmentation Review Examines Treatment Strategies and Evidence Gaps in Skin of Colorhttps://practicaldermatology.com/news/hyperpigmentation-review-examines-treatment-strategies-and-evidence-gaps-in-skin-of-color/2488677/A literature review presented at the 2026 Fall Clinical Dermatology Conference examined mechanisms and treatment strategies for hyperpigmentation disorders, emphasizing persistent gaps in evidence involving patients with skin of color. Susan Taylor, MD, of the University of Pennsylvania, a
- GLP-1 Medication Use Shows No Apparent Impact on Icotrokinra Outcomes in Phase 3 Psoriasis Analysishttps://practicaldermatology.com/news/glp-1-medication-use-shows-no-apparent-impact-on-icotrokinra-outcomes-in-phase-3-psoriasis-analysis/2488675/Concomitant use of glucagon-like peptide-1 (GLP-1)–based medications was not associated with an apparent difference in icotrokinra efficacy, safety, or pharmacokinetics among patients with plaque psoriasis, according to pooled post hoc analyses of the phase 3 ICONIC clinical trial program present
- Comparison Examines GEP Performance Against Melanoma SLNB Risk Thresholdshttps://practicaldermatology.com/news/comparison-examines-gep-performance-against-melanoma-slnb-risk-thresholds/2488674/A comparison of two prospective studies evaluating gene expression profiling (GEP) tests combined with clinicopathologic factors found differences in their ability to identify patients with cutaneous melanoma at low risk for sentinel lymph node (SLN) positivity.1
- International Consortium of Mohs Surgery Launches to Support Global Collaboration in Skin Cancer Carehttps://practicaldermatology.com/news/international-consortium-of-mohs-surgery-launches-to-support-global-collaboration-in-skin-cancer-care/2488635/The International Consortium of Mohs Surgery (ICMS) has officially launched as a global professional association focused on advancing Mohs micrographic surgery and cutaneous oncology through education, research, collaboration, and professional exchange. ICMS leadership signed the organizat
- Short-Course Vunakizumab Shows Rapid Improvement in Pediatric GPPhttps://practicaldermatology.com/news/short-course-vunakizumab-shows-rapid-improvement-in-pediatric-generalized-pustular-psoriasis/2488622/Short-course treatment with vunakizumab was temporally associated with rapid improvement of acute generalized pustular psoriasis (GPP) flares in 3 pediatric patients, according to a case series published in Frontiers in Immunology. Vunakizumab Treatment in Pediatric GPP Flares
- Galderma EADV Data to Explore Nemolizumab, Acne, and Fragile Skinhttps://practicaldermatology.com/news/galderma-eadv-data-to-explore-nemolizumab-acne-and-fragile-skin/2488562/Galderma announced it will be presenting 19 abstracts, including 2 oral presentations, at the 2026 European Academy of Dermatology and Venereology (EADV) Congress, with research spanning inflammatory skin diseases, sensitive and fragile skin, skin longevity, and acne. <